| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibiotic prophylaxis for patients with acute brain injury
|
Klompas, Michael
|
|
|
12 |
5 |
p. 340-341
|
artikel
|
| 2 |
Association of active mobilisation variables with adverse events and mortality in patients requiring mechanical ventilation in the intensive care unit: a systematic review and meta-analysis
|
Paton, Michelle
|
|
|
12 |
5 |
p. 386-398
|
artikel
|
| 3 |
Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial
|
Dahyot-Fizelier, Claire
|
|
|
12 |
5 |
p. 375-385
|
artikel
|
| 4 |
Correction to Lancet Respir Med 2023; 11: 1064–74
|
|
|
|
12 |
5 |
p. e35
|
artikel
|
| 5 |
Corticosteroids in septic shock secondary to community acquired pneumonia: clarity mixed with uncertainty
|
Venkatesh, Balasubramanian
|
|
|
12 |
5 |
p. 338-339
|
artikel
|
| 6 |
Early mobilisation in the intensive care unit: shifting from navigating risks to a patient-centred approach
|
Wozniak, Hannah
|
|
|
12 |
5 |
p. 341-343
|
artikel
|
| 7 |
Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway
|
Trinh, Nhung TH
|
|
|
12 |
5 |
p. e33-e34
|
artikel
|
| 8 |
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
|
Zhong, Hua
|
|
|
12 |
5 |
p. 355-365
|
artikel
|
| 9 |
Genetic factors for ILD—the path of precision medicine
|
Raghu, Ganesh
|
|
|
12 |
5 |
p. 350-352
|
artikel
|
| 10 |
High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study
|
Desai, Sujal R
|
|
|
12 |
5 |
p. 409-418
|
artikel
|
| 11 |
Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial
|
Heming, Nicholas
|
|
|
12 |
5 |
p. 366-374
|
artikel
|
| 12 |
Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial
|
Mo, Yin
|
|
|
12 |
5 |
p. 399-408
|
artikel
|
| 13 |
Lung transplant donors: barriers and ethical considerations
|
The Lancet Respiratory Medicine,
|
|
|
12 |
5 |
p. 337
|
artikel
|
| 14 |
MACE in COPD: addressing cardiopulmonary risk
|
Hurst, John R
|
|
|
12 |
5 |
p. 345-348
|
artikel
|
| 15 |
Optimising antibiotic treatment duration in ventilator-associated pneumonia
|
Johnson, Emma D
|
|
|
12 |
5 |
p. 343-345
|
artikel
|
| 16 |
The persistent mismeasure of spirometry in women
|
Haouzi, Philippe
|
|
|
12 |
5 |
p. e31-e32
|
artikel
|
| 17 |
UK patient with multidrug-resistant tuberculosis
|
Kirby, Tony
|
|
|
12 |
5 |
p. 353-354
|
artikel
|
| 18 |
“Yes! We can end TB,” but remember the sequelae in children
|
Nkereuwem, Esin
|
|
|
12 |
5 |
p. 348-350
|
artikel
|
Tijdschrift beschrijving